RIPC reduced the infiltration of CD3+CD8+ T cells after stroke and increased the proportion of protective B cells and noninflammatory monocytes in peripheral blood, providing neuroprotection in ischemic areas. The gene discussed is CD8A; the disease is stroke disorder.